Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other antidiabetic drugs, a new study suggests.

Four out of 10 U.S. adults ages 18 to 44 have insulin resistance—and most don’t even know it. But what is insulin resistance, ...

In this episode of 'Booked', top endocrinologist Dr. Ambrish Mithal unpacks the world of new-age weight-management drugs, ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

The WHO’s guidance advising against the use of nonsugar sweeteners for weight loss is based on a systematic review published in April 2022 conducted by the organization’s researchers, which ...